Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 22 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

9%

2 trials in Phase 3/4

Results Transparency

8%

1 of 12 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

11Total
Not Applicable (9)
P 4 (2)

Trial Status

Completed12
Unknown5
Recruiting3
Enrolling By Invitation1
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 12 completed trials

Clinical Trials (22)

Showing 20 of 20 trials
NCT06056557Not ApplicableCompleted

Versatility of a Circular Multielectrode Catheter in the Individualized Recognition & Treatment of Atrial Fibrillation and Related Arrhythmias Using Pulsed Field Energy

NCT03488420CompletedPrimary

Canadian EdoxAban(Lixiana®) Registry in Patients With ATrial Fibrillation/Flutter With Confirmed ValvUlar HeaRt DiseasE

NCT06187155Not ApplicableRecruitingPrimary

Impact of Education Level on Clinical Outcomes in Self-INR Managed Patients

NCT06584266RecruitingPrimary

Multimodal Cardiac Imaging Registry in Patients with Atrial Fibrillation

NCT06452823Enrolling By InvitationPrimary

Efficacy and Safety of Catheter Ablation of Atrial Fibrillation in Patients With Thyroid Hormone Stabilization

NCT05009225Active Not RecruitingPrimary

Clinical Decision Support for Atrial Fibrillation and Flutter

NCT03911986Not ApplicableCompletedPrimary

Risk-Based Screening for the Evaluation of Atrial Fibrillation Trial

NCT03862859Phase 4RecruitingPrimary

The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis

NCT05509517Not ApplicableCompletedPrimary

A Clinical Trial of the Use of Remote Heart Rhythm Monitoring With a Smartphone After Cardiac Surgery

NCT03472495Phase 4CompletedPrimary

Oral vs Intravenous Diltiazem for Rapid Atrial Fibrillation/Flutter Trial

NCT03707873Not ApplicableCompletedPrimary

Effect of Targeted Education for Atrial Fibrillation Patients

NCT03788044Not ApplicableCompletedPrimary

Effect of Targeted Education for Atrial Fibrillation Patients (Application Substudy)

NCT04438395UnknownPrimary

Dielectric Tissue Imaging in Cavotricuspid Isthmus Ablation

NCT05159180UnknownPrimary

Development of a New Impedance Mapping System for Ablation of Atrial Arrhythmias in Patients

NCT05008601Completed

Aino ECG Ambulatory Study

NCT04855890Not ApplicableUnknownPrimary

HIgh Power Short Duration Radiofrequency Ablation or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation

NCT03110627Not ApplicableUnknown

Increasing Detection of Sub-Clinical Atrial Fibrillation in Defibrillator Patients With the Use of a VDD-ICD Lead

NCT02623049UnknownPrimary

Direct Oral Anticoagulants Pharmacodynamics in Octogenarian Patients With Atrial Fibrillation

NCT03243604Completed

cARdiotoxicity Profile of aBIraTeRone in prostAte Cancer : a pharmacoviGilancE Study

NCT03377465Not ApplicableCompleted

Biomarkers, Hemodynamic and Echocardiographic Predictors of Ischemic Strokes and Their Influence on the Course and Prognosis

Scroll to load more

Research Network

Activity Timeline